Pay in 4 interest-free payments of $24.40 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Acute CTEP treatment corrects elevated hippocampal long-term depression
also called the epidermal growth factor receptor (EGFR) family
InChi: InChI=1S/C12H14N4O3
Cilomilast and (R)-rolipram are equipotent at suppressing LPS-induced TNF-α formation with -log (IC50) of 7
Vatalanib dihydrochloride Catalog No.:M10925-2 Acute CTEP treatment corrects elevatedVatalanib, also known as PTK787, is an orally bioavailable anilinophthalazine with potential antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet derived growth factor (PDGF) receptor, c Kit, and c Fms. Product